Benign neoplasm of the prostate, classified under ICD-10 code D29.1, refers to a non-cancerous tumor that arises from the prostate gland. This condition is significant as it can lead to urinary symptoms and complications if left untreated. Accurate coding with D29.1 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.
ICD-10 Code D29.1 represents a benign neoplasm of the prostate, which is a non-malignant growth that can cause urinary obstruction and other symptoms. This code should be used in clinical documentation when a patient is diagnosed with this condition, ensuring accurate billing and facilitating appropriate treatment plans.
Benign neoplasms of the prostate are typically caused by hyperplastic changes in the prostate tissue, leading to the formation of non-cancerous tumors. These growths can progress slowly and may require medical intervention if they cause significant urinary symptoms or complications. Prompt diagnosis and management are crucial to prevent further complications.
ICD-10 Code D29.1 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to benign neoplasm of the prostate. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation and continuity of care.
In SOAP notes, ICD-10 Code D29.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of benign neoplasm of the prostate. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of benign neoplasm of the prostate may require hospitalization if complications arise. Treatment options focus on symptom relief and may include surgical intervention if necessary.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D29.1 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate reimbursement for services related to benign neoplasm of the prostate.
| CPT Code | Description |
|---|---|
| 52000 | Cystoscopy, diagnostic, including collection of specimen(s) by brushing or washing, when performed |
| 52400 | Transurethral resection of prostate (TURP) |
| 51798 | Measurement of post-voiding residual urine and/or bladder capacity by ultrasound |
| 99213 | Established patient office visit, Level 3 |
Common Questions About Using ICD-10 Code D29.1 for Benign neoplasm of prostate
What are the common symptoms of benign neoplasm of the prostate?
Common symptoms include increased urinary frequency, urgency, weak urine stream, and nocturia. Patients may also experience pelvic discomfort. These symptoms can significantly impact quality of life.
How is benign neoplasm of the prostate diagnosed?
Diagnosis typically involves a physical examination, digital rectal exam (DRE), and imaging studies. Urinalysis may be performed to rule out infection or other conditions.
What treatment options are available for benign neoplasm of the prostate?
Treatment options include medications such as alpha-blockers and 5-alpha-reductase inhibitors. Surgical options may be considered if symptoms are severe or unresponsive to medical therapy.
Is benign neoplasm of the prostate a serious condition?
While benign neoplasms are non-cancerous, they can lead to significant urinary symptoms and complications if not managed appropriately. Regular monitoring and treatment are essential.
Clinical Notes
SOAP notes
DAP notes
AI medical notes